-
Emergency
-
Apollo Lifeline
-
Emergency
Morning Slots
AFTERNOON Slots
Dr P Vijay Anand Reddy
Radiation Oncology
30+ Years Experience
MBBS; MD (Radiotherapy); DNB (Radiotherapy); Medical Oncology (ESMO); FUICC; FNDM; FUICC
Apollo Health City Jubilee Hills
English,Hindi,Telugu
Mon - Fri
10:00 -17:00
Dr P Vijay Anand Reddy
Radiation Oncology
30+ Years Experience
MBBS; MD (Radiotherapy); DNB (Radiotherapy); Medical Oncology (ESMO); FUICC; FNDM; FUICC
Apollo Health City Jubilee Hills
English,Hindi,Telugu
Mon - Fri
10:00 -17:00
Description
Dr. Vijay Anand Reddy P is a highly experienced Radiation Specialist Oncologist based in Hyderabad, Telangana, with an impressive career spanning over 30 years in the field of oncology. He has dedicated his practice to providing comprehensive care to patients battling cancer, employing advanced radiation therapy techniques to ensure optimal treatment outcomes. Dr. Reddy P holds multiple esteemed qualifications including MBBS, MD in Radiotherapy, DNB in Radiotherapy, and further specialization in Medical Oncology. He is also recognized with fellowships such as FUICC and FNDM, which highlight his commitment to continuous learning and excellence in his practice.
Fluent in English, Hindi, and Telugu, Dr. Reddy P ensures effective communication with a diverse patient population, offering personalized care that considers the unique needs of each individual. His focused approach to radiation oncology makes him a trusted name among patients seeking precise and compassionate treatment for complex conditions.
Throughout his career, Dr. Reddy P has remained at the forefront of innovations in the field of radiation therapy, utilizing cutting-edge technologies and techniques to enhance the effectiveness of treatment while prioritizing the safety and comfort of his patients. His extensive expertise, coupled with a deep commitment to patient care, makes Dr. Vijay Anand Reddy P a valuable asset to the medical community and a reliable choice for those seeking specialized oncological care.
Experience
- Director & Sr. Consultant, Apollo Cancer Hospital, Hyderabad, since April 2002.
- Consultant Ocular Oncologist, L.V. Prasad Eye Institute since 1998.
- Stereotactic Radiosurgery Fellowship at Klinikum Frankfurt (Oder) GmbH, Frankfurt, Germany, March 2010.
- Ocular Oncology Fellowship at Children's Hospital of Philadelphia, USA & Will's Eye Hospital, Philadelphia, USA, May-June 2003.
- Head & Neck Oncology Fellowship: Peter MacCallum Cancer Institute, Melbourne, Australia, July-August 1998.
- Head & Neck Brachytherapy Observership: The Memorial Sloan Kattering Cancer Centre, New York, June 1995.
- Nargis Dutt Memorial Cancer Foundation Fellowship: The New York Hospital, Medical Centre of Queens, New York, May - July 1995.
- Clinical Observership: Christie Hospital, Manchester, United Kingdom, Sept 1992.
- Clinical Oncology Fellowship: The Meyerstein Institute of Oncology, The Middle Sex Hospital, London, July-Sept 1992.
- Associate Professor of Radiation Oncology, Kakatiya Medical College, Warangal, April 1999-April 2001.
- Assistant Professor, MNJ Institute of Oncology, Red Hills, Hyderabad, April 1992-1999.
- Clinical Oncology Fellowship: Adyar Cancer Institute, Chennai, Jan 1990.
- Medical Oncology Fellowship: Nizam Institute of Medical Sciences, Hyderabad, Sept 1990.
- Radiation Oncology Fellowship: Tata Memorial Hospital, Mumbai, March - August 1990.
- Elected as the Chairman ICRO (Indian College of Radiation Oncology) a prestigious body, December 2012.
Memberships
- Full Member of American Society of Clinical Oncology (ASCO)
- Full Member of American Society for Radiation Oncology (ASTRO)
- Permanent Member of European Society of Medical Oncology (ESMO)
- Permanent Member of “Union for International Cancer Control”, UICC, Geneva
- President of Association of Radiation Oncologists of India (AROI)
- President of Association of Radiation Oncologists of India (AROI), Telangana Chapter
- President of Association of Radiation Oncologists of India (AROI), AP Chapter (Past)
- Member of Indian College of Radiation Oncology (ICRO)
- Chairman, Indian College of Radiation Oncology (ICRO), INDIA
- Member of Indian Society of Oncology (ISO)
- Member of Civil Assistant Surgeon’s Association, Andhra Pradesh
- Member of Indian Medical Association (IMA)
- Member of Indian Co-operative Oncology Network (ICON)
- Member of Indian Brachytherapy Society (IBS)
Research & Publication
- Aqueous Deficient Dry Eye Syndrome Post Orbital Radiotherapy: A 10-year Retrospective Study – Translational Vision Science & Technology, June 2017; Vol. 6; No. 3; Article 19; Pg. 1-9.
- Therapy and Lacrimal Drainage System Toxicity: Nasal Localization Studies using Whole body Nuclear Scintigraphy and SPECT-CT – The American Society of Ophthalmic Plastic and Reconstructive Surgery 2014; Vol. XX; No. XX; Pg. 1-4.
- Ophthalmologic Pathology: SY20-2 What is your Diagnosis? – Royal College of Pathologists of Australia, Taylor & Francis October 2014; Vol. 46 (2); Pg. S30
- Orbital Alveolar soft-part Sarcoma: Clinico-pathological profiles, management and Outcomes – Journal of Cancer Research and Therapeutics; April-June 2014; Vol. 10; Issue. 2; Pg. 294-298.
- Management and Outcome of Retinoblastoma with Vitreous Seeds – American Academy of Ophthalmology Feb 2014; Vol. 121 (2); Pg. 517-524
- Lacrimal Surgery Glorious past, exciting present era and the audacity of hope for a brilliant future – Saudi Journal of Ophthalmology 2014; Vol. 28; Pg. 1-2.
- Distant metastatic Retinoblastoma without Central Nervous system involvement – Indian Journal of Ophthalmology July 2013; Vol. 61(7); Pg. 357-359.
- Primary Intraocular Malignant Extrarenal Rhabdoid tumor: a Clinicpathological Correlation – Journal of Pediatric Ophthalmology and Strabismus April 2013; Vol. 50; Pg. e18-20.
- Adenoid cystic carcinoma of the lacrimal gland: role of nuclear survivin (BIRC5) as a prognostic marker – Histopathology May 2013; Vol. 62(6); Pg. 840-846.
- Distant Metastatic Retinoblastoma without Central Nervous System involvement – Indian Journal of Ophthalmology April 2013; PubMed ID - 23548316.
- Optic Nerve Meningeal Hemangiopericytoma: A Clinicopathological Case Report – Survey of Ophthalmology January 2013; pii: S0039-6257(12)00248-2. doi: 10.1016; PubMed ID – 23294915.
- Radiation Oncology in 21st Century – Changing the Paradigms – Apollo Medicine June 2012; Vol. 9; No. 2; Pg. 115-125.
- Orbital Plasmablastic Lymphoma: A Clinico-Pathological Correlation of a rare disease and review of Literature - Clinical Ophthalmology (Auckland, N.Z.) 6: 2012; Pg. 2049-2057.
- Evaluation of HER-2/neu status in Breast Cancer Specimens using Immunohistochemistry (IHC) & Fluorescence in-situ hybridization (FISH) assay – Indian Journal of Medical Research March 2012; Pg. 312-317.
- Establishing Human Lacrimal Gland Cultures with Secretory Function - PLoS One. 2012; Vol. 7(1); e29458.
- High Dose Rate Interstitial Brachytherapy in Carcinoma Eyelid: Can it be a Primary treatment Modality? – Journal of Cancer Research and Therapeutics Oct-Dec 2011; Vol. 7(4); Pg. 498-499.
- First Indian Experience with Shaped Beam Radiosurgery of Cranial and Spinal Lesions on Novalis-Tx Linear Accelerator with Exac Trac 6D Robotic Couch – 10th International Stereotactic Radiosurgery Society Congress “Brain & Body Radiosurgery”, Paris 2011; Pg. 1166.
- Set-up Accuracy with Frameless Radiosurgery of Intracranial Lesions using Exac Trac 6-D Robotic Couch on Novali-Tx Linear Accelerator – 10th International Stereotactic Radiosurgery Society Congress “Brain & Body Radiosurgery”, Paris 2011; Pg. 1147.
- Comparison of Intensity Modulated Stereotactic Radiosurgery with Conventional Stereotactic Conformal Beam Radiosurgery in Vestibular Schwannomas – 10th International Stereotactic Radiosurgery Society Congress “Brain & Body Radiosurgery”, Paris 2011; Pg. 1003.
- The New Radiation Technology and Techniques – Does it Matter in Gynec Cancer? – Annals of IMA Academy of Medical Specialities 2011; Pg. 49-53.
- Evaluation of Human Lacrimal Gland Cultures for Secretory Function and Putative Stem Cells – Indian Eye Research Group (IEGR) 2011; Pg. 84.
- Orbital Retinoblastoma: Where do we go from here? – Journal of Cancer Research and Therapeutics May 2011; Vol. 7(1); Pg. 11-14.
- Cultivation and Characterization of Human Lacrimal Gland Cells for Potential Clinical Application – Indian Eye Research Group (IERG) 2010; Vol. 1; Pg. 80.
- Ruthenium 106 Plaque Brachytherapy : Indications and Outcome in Ocular Tumors – Indian Eye Research Group (IERG) 2010; Vol. 1; Pg. 110-111.
- Ruthenium 106 Plaque Brachytherapy : Indications and Outcome in Ocular Tumors – Shifting Paradigms in Head and Neck Oncology (IFHNOS) 2010; Vol. 1; Pg. 233
- Orbital Retinoblastoma: Present status and future challenges – A review – Saudi Journal of Ophthalmology 2010, Vol. 25(2); Pg. 159-167.
- Largest series of orbital Schwannoma: Clinical manifestations and outcomes (Abs) - Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 131.
- Genotype-Phenotype and Clinical correlation in Retinoblastoma (Abs) - Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 129.
- RBI Gene Mutations in Ratinoblastoma and its clinical correlation – Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 119-123.
- Ruthenium 106 Plaque Brachytherapy: Indications and Outcomes in Ocular Tumors (Abs) - Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 121.
- A typical presentation of Ciliary body Medulloepithelioma (Abs) - Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 116.
- Histopathology of Retinoblastoma after primary Chemotherapy (Abs) - Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 100.
- Evisceration in unsuspected Intraocular Tumors - Archives of Ophthalmology March 2010; Vol. 128(3); Pg. 372-379.
- Histopathologic changes in Uveal melanoma after Ruthenium 106 Brachytherapy – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2) :S98
- Cultivation and characterization of Lacrimal and Salivary Gland Cells for Potential Clinical application – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2) :S98
- Role of HPV, Cell cycle markers and epigenetic modifications at DNMT3L region in Ocular surface Squamous Neoplasia – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2) :S97
- HPV for Cervical Cancer Screening: Is the era of the Molecular Pap Smear upon us? – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2) :S97
- Ruthenium 106 Plaque Brachytherapy : Indications and outcome in Ocular Tumors – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2):S88
- Cervical Cancer Screening: Role of Serotyping of HPV as bridge of Cytopathology and Molecular typing? – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2):S75
- Genotype and phenotype correlation analysis in Retinoblastoma – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2):S75
- Sebaceous Carcinoma of the Eyelid Metastasizing to the Lacrimal Sac after 5 years – Orbit (Amsterdam, Netherlands) October 2009; Vol. 28(5); Pg.309-312.
- Histopathology of retinoblastoma after primary chemotherapy – Proceedings of the XIV International Congress of Ocular Oncology, Cambridge 2009; Pg. 296.
- Orbital Schwannoma: Clinical manifestations and outcomes – Proceedings of the XIV International Congress of Ocular Oncology, Cambridge 2009; Pg. 146.
- A typical presentation of Ciliary body Medulloepithelioma – Proceedings of the XIV International Congress of Ocular Oncology, Cambridge 2009; Pg. 46.
- Histopathologic risk factors in Retinoblastoma in India - Archives of Pathology & Laboratory Medicine August 2009; Vol. 133(8); Pg. 1210-1214.
- Extramedullary Leukemia in Children presenting with Proptosis – Journal of Hematology & Oncology 2009; Vol. 2; Pg. 4.
- Retinoblastoma – Advances in Management – Apollo Medicine Sept. 2008; Vol. 5; No. 3; Pg. 183-189.
- Proptosis as a Manifestation of Acute Myeloid Leukemia – Pediatric Clinics of North India 2008.
- Metastasis to the Eye and Orbit from Renal Cell Carcinoma – A Report of Three Cases and Review of Literature - Survey of Ophthalmology Mar-Apr 2007; Vol. 52(2); Pg. 213-223.
- Systemic Metastasis Following Hyphema Drainage in an Unsuspected Retinoblastoma – Journal of Pediatric Ophthalmology and Strabismus Mar-Apr 2007; Vol. 44; Pg. 120-123.
- Orbital Embryonal Rhabdomyosarcoma in association with Neurofibromatosis type 1 – Ophthalmic Plastic and Reconstructive Surgery Mar-Apr 2007; Vol. 23(2); Pg. 147-148.
- Acute Respiratory Distress Syndrome due to Strongyloides Stercoralis in Non-Hodgkin's Lymphoma – The Indian Journal of Chest Diseases & Allied Sciences Jan-Mar 2006; Vol. 48(1); Pg. 67-69.
- Ruthenium-106 Plaque Brachytherapy for the treatment of Diffuse Choroidal Haemangioma in Sturge-Weber Syndrome - Indian Journal of Ophthalmology Dec. 2005; Vol. 53(4); Pg. 274-275.
- Neoadjuvant Chemotherapy in the Management of Sebaceous Gland Carcinoma of the Eyelid with Regional Lymph Node Metastasis - Ophthalmic Plastic and Reconstructive Surgery July 2005; Vol. 21(4); Pg. 307-309.
- Concurrent Chemo Radiotherapy followed by Intraluminal Brachytherapy in non-metastatic carcinoma oesophagus – Journal of Clinical Oncology, ASCO Annual Meeting Proceedings, Vol. 22, 14S (July 15 Supplement), 2004 : 4201.
- Clinicopathologic findings in Choroidal Melanomas after failed Transpupillary Thermotherapy - American Journal of Ophthalmology March 2004; Vol. 137(3); Pg. 594-595; author reply 595-596
- Histopathology of Retinoblastoma after Primary Chemotherapy – Proceedings of the XI International Congress of Ocular Oncology, Hyderabad India January 2004; ICOO Secretariat & L.V. Prasad Eye Institute; Pg. 94.
Cancer Awareness Lectures:
- “Breast Cancer Awareness” at Rotary Club of Hyderabad, Hyderabad on January 23, 2015
- “Paradigm Shift in Cancer Management” at Southern Sector Conference cum CME, CH, CRPF, Hyderabad on June 12, 2014
- “Cancer is Curable! – believe it!” at IAS Officers Wives Association, Hyderabad on March 26, 2014
- “We can prevent and cure Cancer” CME at Vizag Steel Plant Commemoration Day, Visakhapatnam on December 27, 2013
- “Cancer Awareness” at BHEL, Bhopal on October 23, 2013
- “Overview of the Management of Common Cancers” at Shadan Inst. of Medical Sciences, Hyderabad on May 2, 2013.
- “Before & after Cancer” at TATA Consultancy Services, Hyderabad on February 19, 2013.
- “Cancer Awareness” at GE Energy – Hyderabad Technology Center, HITEC City, Hyderabad on October 18, 2012.
- “Cancer – Prevention, Detection & Treatment” at International Advanced Research Centre for Powder Metallurgy & New Materials (ARCI), Hyderabad on March 21, 2012.
- “Cancer in Women” at St. Ann’s College for Women, Mehdipatnam, Hyderabad on October 25, 2011.
- “Cancer in Women” at CME at Padma Vibhushan Nawab Mehdi Nawaz Jung Clinic & Charitable Trust, Darulshifa, Hyderabad on October 23, 2011.
- “Yes, you can prevent Cancer in Women” at GE-Energy, Hyderabad Technology Center, Hitec City, Hyderabad on March 8, 2010.
Conferences Organized:
- Organized 3rd biennial APOLLO CANCER CONCLAVE & 7th Biennial CANCER CI – 2017 from February 2–5, 2017 at HICC, Hyderabad.
- Organized 20th ICRO PG Teaching Program on “Paediatric Cancers” from July 18-19, 2015 organized by Apollo Cancer Hospital, Hyderabad.
- Organized 2nd biennial APOLLO CANCER CONCLAVE & 6th Biennial CANCER CI – 2015 from February 4–8, 2015 at HICC, Hyderabad.
- Organized 18th ICRO PG Teaching Program on “Cancer of Esophagus, Ca. Stomach & Ca. Rectum” from September 27-28, 2014 at RCC, Trivandrum.
- Organized 17th ICRO PG Teaching Program on “Treatment of Lung Cancer” from July 12-13, 2014 at Tata Medical Centre, Kolkata.
- Organized 16th ICRO PG Teaching Program on “Radiotherapy Planning from 2D to 3D” from April 26-27, 2014 at Indira Gandhi Medical College, Shimla.
- Organized 15th ICRO PG Teaching Program on “Clinical Trials, Statistics & Thesis Writing” from September 7-8, 2013 at Mahavir Cancer Sansthan, Patna.
- Organized 14th ICRO PG Teaching Program on “Concurrent Chemoradiotherapy – Guidelines and Evidence” from April 27-28, 2013 at Maulana Azad Medical College, New Delhi.
- Organized 5th Biennial International Conference “CANCER CI – 2013” from February 8–10, 2013 at TAJ Krishna, Hyderabad.
- Organized 4th Biennial International Conference “CANCER CI – 2011” from February 25–27, 2011 at TAJ Krishna, Hyderabad.
- Organized 31st National Annual Conference of Association of Radiation Oncologists of India “AROICON – 2009” from November 26–29, 2009 at TAJ Krishna, Hyderabad.
- Organized 3rd Biennial International Conference “CANCER CI – 2008” from February 9–10, 2008 at TAJ Krishna, Hyderabad.
- Organized 2nd Biennial International Conference “CANCER CI – 2006” from February 11–12, 2006 at TAJ Krishna, Hyderabad.
- Organized 1st International Translational Research Conference “B2B2K5” from March 19-20, 2005 at CCMB, Hyderabad.
- Organized XI International Congress of Ocular Oncology Conference – 2004 from January 23-27, 2004 at Shilpakala Vedika, Hyderabad.
- Organized 1st International Conference "CANCER CI – 2003" from August 23-24, 2003 at TAJ Residency, Hyderabad.
- Second National Conference on Vascular Restenosis – 2001.
- National Conference of Indian Society of Oncology (ISO) – 2000.
- Intracoronary Brachytherapy Conference – 1998.
- Indo - US Cancer Update '94 on September 1994 at Hyderabad.
- XIV National Conference of Association of Radiation Oncologist of India (AROI), January 1993 at Hyderabad.
List of Treatments
Osteosarcoma Treatment
Osteosarcoma Treatment
List of Conditions
Bladder Cancer
Brain Tumor
Chondrosarcoma
Colon Cancer
Esophageal Cancer
Glioma
Lung Cancer
Merkel cell carcinoma
Mouth cancer
Nonmelanoma skin cancer
Osteosarcoma
Retinoblastoma
Throat Cancer
Salivary Gland Tumors
Meningioma
Wilms Tumor
vasc
vulvar-cancer
Cervical Cancer
Breast Lumps
Bladder Cancer
Brain Tumor
Chondrosarcoma
Colon Cancer
Esophageal Cancer
Glioma
Lung Cancer
Merkel cell carcinoma
Mouth cancer
Nonmelanoma skin cancer
Osteosarcoma
Retinoblastoma
Throat Cancer
Salivary Gland Tumors
Meningioma
FAQ's
Dr. Vijay Anand Reddy Palkonda's medical practice is located at Apollo Hospitals Jubilee Hills. This hospital offers comprehensive healthcare services and advanced medical technology.
Dr. Vijay Anand Reddy Palkonda is frequently sought for his expertise in External Beam Radiation for Prostate Cancer, Hormone Therapy for Breast Cancer, and Hormone Therapy for Prostate Cancer. For a detailed list of his specializations, please refer to his professional profile.
Dr. Vijay Anand Reddy Palkonda holds an MBBS, MD in Radiotherapy, and a DNB in Radiotherapy.
Dr. Vijay Anand Reddy Palkonda specializes in Radiation Oncology.
Dr. Vijay Anand Reddy Palkonda has 32 years of experience in oncology.
Dr. Vijay Anand Reddy Palkonda serves as the Director & Senior Consultant Oncologist at Apollo Cancer Centres. His leadership has been instrumental in establishing the institute as a leading cancer center of excellence in India, renowned for scientific innovation, advanced technology, and compassionate patient care. A highly respected oncologist, Dr. Reddy is known for his commitment to his patients, demonstrated through high cure rates comparable to top global cancer centers and his extensive experience treating both domestic and international patients.
